Evidence map›Paper›PMID 12117877›Full record

ArticleGut2002

Expression of CDX2 in normal and neoplastic human colon tissue and during differentiation of an in vitro model system.

D Qualtrough, T Hinoi, E Fearon, C Paraskeva

Open access · bronzeAbstract readComparative Study
In one paragraph

Article in Gut, 2002. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
4.0field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 57 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Site-specific biology and pathology of gastroenteropancreatic neuroendocrine tumors.Virchows Archiv : an international journal of pathology · 2007
    Review
  16. Article
  17. Article
  18. CDX2 as a marker of intestinal EC-cells and related well-differentiated endocrine tumors.Virchows Archiv : an international journal of pathology · 2004
    Article
  19. Article
  20. CDX2 immunoreactivity in primary and metastatic ovarian mucinous tumours.Virchows Archiv : an international journal of pathology · 2003
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 4 institutions in 3 countries.

D QualtroughCancer Research UK, Colorectal Tumour Biology Research Group, Department of Pathology and Microbiology, School of Medical Sciences, University of Bristol, University Walk, Bristol BS8 1TD, UK.
T Hinoi
E Fearon
C Paraskeva
Ann Arbor VA Medical Center · USCancer Research UK · GBUniversity of Bristol · GBUniversity of Michigan–Ann Arbor · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe Cdx genes are expressed in the colorectal epithelium and are frequently downregulated during tumorigenesis. Overexpression of Cdx genes has been shown previously to result in cellular differentiation.

aimTo study expression of CDX2 in normal and neoplastic human colon using a newly isolated monoclonal antibody. To define expression of CDX1 and CDX2 in an in vitro model system of colorectal tumour progression and to ascertain whether these are subject to regulation during differentiation.

methodsNormal and neoplastic human colon was immunostained for CDX2. CDX1 and CDX2 expression was assayed in cell lines derived from premalignant colonic adenomas by western blotting. Differentiation was induced by sodium butyrate treatment or post confluent growth, and changes in CDX expression compared with carcinoma cell lines with low levels of CDX expression.

resultsCDX2 protein displayed no gradient of expression within the colonic crypt. Cell lines derived from adenomas, with high levels of CDX1 and CDX2, showed no regulation of these proteins when induced to differentiate by butyrate or confluency. CDX expression in these cell lines was independent of their APC or Ras status. CDX1 and CDX2 were expressed at very low levels in some carcinoma cell lines and were modestly upregulated on differentiation but were not restored to levels seen in adenoma cells.

conclusionThe lack of significant regulation on cellular differentiation and the absence of a detectable gradient in the crypt implies that CDX2 may confer tissue specificity but may not play the previously suggested role in crypt patterning.

Indexed as

AdenomaAnimalsBlotting, WesternButyratesCDX2 Transcription FactorCell DifferentiationColonColonic NeoplasmsDisease ProgressionHomeodomain ProteinsHumansImmunohistochemistryMiceTrans-ActivatorsTumor Cells, CulturedButyratesCDX1 protein, humanCdx1 protein, mouseCDX2 protein, humanCDX2 Transcription FactorHomeodomain ProteinsTrans-Activators

Identifiers

PMID12117877
PMCPMC1773308
OpenAlexW2101904652

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.